Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

beta-2 Microglobulin antibody (CF®594)

This Mouse Monoclonal antibody specifically detects beta-2 Microglobulin in FACS, IF and IHC (f). It exhibits reactivity toward Human and Non-Human Primate.
Catalog No. ABIN6175158

Quick Overview for beta-2 Microglobulin antibody (CF®594) (ABIN6175158)

Target

See all beta-2 Microglobulin (B2M) Antibodies
beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

Reactivity

  • 241
  • 55
  • 48
  • 33
  • 11
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Non-Human Primate

Host

  • 149
  • 130
  • 9
  • 6
  • 2
  • 1
Mouse

Clonality

  • 163
  • 133
  • 1
Monoclonal

Conjugate

  • 135
  • 35
  • 26
  • 14
  • 13
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This beta-2 Microglobulin antibody is conjugated to CF®594

Application

  • 167
  • 136
  • 101
  • 88
  • 79
  • 53
  • 47
  • 39
  • 26
  • 21
  • 17
  • 17
  • 14
  • 13
  • 11
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

B2M-1118
  • Purpose

    Mouse Monoclonal anti-Beta-2 Microglobulin (B2M) (B2M/1118), CF594 Conjugate

    Characteristics

    Beta-2 microglobulin is a 12 kDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Full length recombinant human B2M protein

    Isotype

    IgG1 kappa
  • Application Notes

    Immunohistology formalin-fixed 0.5-1 μg/mL
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes
    • Immunofluorescence 0.5-1 μg/mL
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Optimal dilution for a specific application should be determined by user

    Comment

    HL-60 or HeLa cells. Melanomas and Lymphoma. Carcinoma of Stomach, Cervix, Endometrial, Kidney or Colon.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light
  • Target

    beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

    Alternative Name

    Beta-2 Microglobulin (B2M)

    Background

    B2M, Beta 2 microglobin, Beta 2 microglobulin, Beta chain of MHC class I molecules, Beta-2-microglobulin form pI 5.3, Hdcma22p

    Molecular Weight

    12 kDa

    Gene ID

    567, 534255

    UniProt

    P61769

    Pathways

    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Chat with us!